Checking up on past Endpoints 11 winners: Who went public, who got bought and who's still working
You win some, you lose some — that’s the risk of trying to predict the next hot biotechs.
Since 2018, the Endpoints 11 awards have identified …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
